JCV detection in multiple sclerosis patients treated with natalizumab

Journal of Neurology

Volumn 257, Issue 6, 2010, Pages 954-958

  Sadiq, Saud A ^a   Puccio, Lauren M ^a   Brydon, Edward W A ^a  

^a Multiple Sclerosis Research Center of New York Inc   (United States)

Author keywords

Cerebrospinal fluid; JC virus; Multiple sclerosis; Natalizumab; Progressive multifocal leukoencephalopathy

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; METHOTREXATE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOXANTRONE; NATALIZUMAB; VIRUS DNA; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BK VIRUS; BK VIRUS INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; JC VIRUS; JC VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POLYOMAVIRUS INFECTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROSPECTIVE STUDY; VIRUS DETECTION; VIRUS REPLICATION; BLOOD; CEREBROSPINAL FLUID; COMPLICATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIROLOGY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BK VIRUS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC FACTORS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POLYOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; TUMOR VIRUS INFECTIONS; ANTIBODIES, MONOCLONAL, HUMANIZED;

EID: 77954428012     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5444-4     Document Type: Article

References (18)

1. A Aksamit 2006 Review of progressive multifocal leukoencephalopathy and natalizumab Neurologist 12 6 293 298 10.1097/01.nrl.0000250948.04681.96 17122725 (Pubitemid 44813665)
2. R Alvarez-Lafuente M Garcia-Montojo V De Las Heras M Bartolomé R Arroyo 2007 JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event Mult Scler 13 590 595 10.1177/1352458506073116 1:CAS:528:DC%2BD2sXotFyksb4%3D 17548437 (Pubitemid 46939524)
3. A Behzad-Behbahani PE Klapper PJ Vallely GM Cleator A Bonington 2003 BKV-DNA and JCV-DNA in CSF of patients with suspected meningitis or encephalitis Infection 31 374 378 1:STN:280:DC%2BD2c%2FjsVGruw%3D%3D 14735377 (Pubitemid 38005365)
4. A d'Arminio Monforte P Cinque L Vago A Rocca A Castagna C Gervasoni, et al.. 1997 A comparison of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients J Neurol 244 35 39 10.1007/PL00007727 9007743 (Pubitemid 126437530)
5. C Elsner K Dorries 1992 Evidence of human polyomavirus BK and JC infection in normal brain tissue Virology 191 72 80 10.1016/0042-6822(92)90167-N 1:STN:280:DyaK3s%2FjtlWlsg%3D%3D 1329338
6. P Ferrante R Caldarelli-Stefano E Omodeo-Zorini L Vago R Boldorini G Costanzi, et al.. 1995 PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy J Med Virol 47 219 225 10.1002/jmv.1890470306 1:CAS:528:DyaK28Xjsl2l 8551272
7. IW Fong CB Britton KE Luinstra E Tomas JB Mahony 1995 Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy J Clin Microbiol 33 484 486 1:CAS:528: DyaK2MXjvFOgu7c%3D 7714213
8. E Iacobaeus C Ryschkewitsch M Gravell M Khademi E Wallstrom T Olsson, et al.. 2009 Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA Mult Scler 15 28 35 10.1177/1352458508096870 1:STN:280:DC%2BD1M%2FhslWgsw%3D%3D 18805840
9. IJ Koralnik D Boden VX Mai CI Lord NL Letvin 1999 JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy Neurology 52 253 1:STN:280:DyaK1M7ivFOhsg%3D%3D 9932940 (Pubitemid 29059048)
10. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
11. H Lindå A von Heijne EO Major C Ryschkewitsch J Berg T Olsson C Martin 2009 Progressive multifocal leukoencephalopathy after natalizumab monotherapy N Engl J Med 361 1081 1087 10.1056/NEJMoa0810316 19741229
12. CJ Perrons JD Fox SB Lucas NS Brink RS Tedder RF Miller 1996 Detection of polyomaviral DNA in clinical samples from immunocompromised patients: correlation with clinical disease J Infection 32 205 209 10.1016/S0163-4453(96) 80020-X 1:STN:280:DyaK28zosFykuw%3D%3D (Pubitemid 26196468)
13. CH Polman PW O'Connor E Habrdova M Hutchinson L Kappos DH Miller, et al.. 2006 A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis N Engl J Med 354 899 910 10.1056/NEJMoa044397 1:CAS:528:DC%2BD28XitVertL4%3D 16510744 (Pubitemid 43313657)
14. RM Ransohoff 2007 Natalizumab for multiple sclerosis N Engl J Med 356 2622 2629 10.1056/NEJMct071462 1:CAS:528:DC%2BD2sXmslKjs7s%3D 17582072 (Pubitemid 46961007)
15. MD Reploeg GA Storch D Clifford 2001 BK virus: a clinical review Clin Infect Dis 33 191 202 10.1086/321813 1:STN:280:DC%2BD3MzlslGjuw%3D%3D 11418879 (Pubitemid 32643334)
16. RA Rudick WH Stuart PA Calabresi C Confavreux SL Galetta EW Radue, et al.. 2006 Natalizumab plus interferon beta-1a for relapsing multiple sclerosis N Engl J Med 354 911 923 10.1056/NEJMoa044396 1:CAS:528:DC%2BD28XitVertLw%3D 16510745 (Pubitemid 43313658)
17. Tysabri full prescribing information. Biogen Idec. http://www.tysabri. com/tysbProject/tysb.portal/-baseurl/twoColLayout/SCSRepository/en-US/tysb/home/ product-information/index.html. Accessed 11 Dec 2007
18. TA Yousry EO Major R Ryschkewitsch G Fahle S Fischer J Hou, et al.. 2006 Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy N Engl J Med 354 924 933 10.1056/NEJMoa054693 1:CAS:528:DC%2BD28XitVertLs%3D 16510746 (Pubitemid 43313659)